Exploring Ketamine’s Effects on Depression, PTSD, and Biological Ageing: New Insights from Epigenetics
Ketamine is making waves as an antidepressant, but new research shows it may also slow cellular aging. This study reveals that a short course of ketamine infusions reduced both depression and PTSD symptoms and lowered participants’ biological age. By tracking DNA changes, researchers uncovered promising epigenetic effects, particularly with OMICmAge biomarkers, which may open doors for treating mental health and aging together.